Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10628	Companies
225863	Keywords
154382	Articles
119513	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 05/17/2025 at 00:00, 1 year 1 month ago

Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
Onco-Innovations Limited to transfer listing of Common Shares to Cboe Canada from CSE; trading on Cboe Canada begins on May 22, 2025. Company aims for investor trust, liquidity, and visibility under existing ticker symbol 'ONCO'

Common Shares Listing Transfer Onco-Innovations Limited Cboe Canada Investor Trust
BRIEF

published on 04/25/2025 at 00:05, 1 year 1 month ago

Onco-Innovations' Inka Health Partners with AstraZeneca Canada

Real-world Evidence Onco-Innovations Inka Health AstraZeneca Canada Drug Submission
BRIEF

published on 04/25/2025 at 00:05, 1 year 1 month ago

Inka Health d'Onco-Innovations s'associe à AstraZeneca Canada

Preuves Du Monde Réel Onco-Innovations AstraZeneca Canada Inka Santé Soumission De Médicament
PRESS RELEASE

published on 04/25/2025 at 00:00, 1 year 1 month ago

Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access

Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
BRIEF

published on 04/18/2025 at 00:05, 1 year 2 months ago

Onco-Innovations Partners with Dalton Pharma for PNKP Isotope Synthesis

Cancer Research Onco-Innovations PNKP Technology Dalton Pharma Services ADME Studies
BRIEF

published on 04/18/2025 at 00:05, 1 year 2 months ago

Onco-Innovations s'associe à Dalton Pharma pour la synthèse de l'isotope PNKP

Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Services Pharmaceutiques Dalton Études ADME
PRESS RELEASE

published on 04/18/2025 at 00:00, 1 year 2 months ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential

Colorectal Cancer Survival Rate Onco-Innovations Dalton Pharma Services PNKP Inhibitor
BRIEF

published on 04/17/2025 at 01:35, 1 year 2 months ago

Onco-Innovations Plans $600,000 Private Placement

Private Placement Warrants Regulatory Approval Securities Offering Corporate Funding
BRIEF

published on 04/17/2025 at 01:35, 1 year 2 months ago

Onco-Innovations prévoit un placement privé de 600 000 $

Placement Privé Offre De Titres Mandats Financement Des Entreprises Approbation Réglementaire
PRESS RELEASE

published on 04/17/2025 at 01:30, 1 year 2 months ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 400,000 units at $1.50 per unit, for gross proceeds of up to $600,000, with plans for cancer research and treatment advancements

Private Placement Securities Oncology Cancer Research Onco-Innovations Limited

Accesswire

Published on 06/24/2026 at 13:05, 11 minutes ago

Faraday Copper Reports Drill Results Including Near-Surface Copper Mineralization in the American Eagle Area
Published on 06/24/2026 at 13:00, 16 minutes ago

Aston Bay Provides Update on the Storm Copper Project - Advancing Towards Development
Published on 06/24/2026 at 10:12, 3 hours 4 minutes ago

Silver Range Expands Alamo Gold-Copper Target
Published on 06/24/2026 at 03:15, 10 hours 1 minute ago

Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 13 hours 16 minutes ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

View all ACCESSWIRE

EQS Group

Published on 06/24/2026 at 13:00, 16 minutes ago

Nebius AI Cloud 3.6 strengthens developer experience and governance for production operations
Published on 06/24/2026 at 12:58, 17 minutes ago

EQS-Adhoc: init innovation in traffic systems SE successfully completes cash capital increase through accelerated bookbuilding
Published on 06/24/2026 at 12:50, 26 minutes ago

Power World Live from Munich: The Next Generation of Carbon-Neutral Heating Infrastructure
Published on 06/24/2026 at 12:48, 27 minutes ago

NFON AG AGM 2026: Improved profitability and progress in AI growth areas characterise FY 2025
Published on 06/24/2026 at 12:40, 36 minutes ago

Risen Energy Showcases Full-Scenario Innovations at Intersolar Europe 2026

Les Echos

Published on 06/24/2026 at 09:30, 3 hours 46 minutes ago

CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”
Published on 06/23/2026 at 19:47, 17 hours 28 minutes ago

GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 17 hours 28 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 18 hours 6 minutes ago

GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 18 hours 6 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026

View all LES ECHOS COMFI WIRE